Sudden Natural Death in Infancy and Early Childhood Involving the Nervous System, a Large Number of Which Are Due to Vascular Or Infective Disorders26
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Pathologic Rupture of the Spleen in a Patient with Acute Myelogenous Leukemia and Leukostasis
rev bras hematol hemoter. 2014;36(4):290–292 Revista Brasileira de Hematologia e Hemoterapia Brazilian Journal of Hematology and Hemotherapy www.rbhh.org Case report Pathologic rupture of the spleen in a patient with acute myelogenous leukemia and leukostasis Gil Cunha De Santis ∗, Luciana Correa Oliveira, Aline Fernanda Ramos, Nataly Dantas Fortes da Silva, Roberto Passetto Falcão Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil article info abstract Article history: Rupture of the spleen can be classified as spontaneous, traumatic, or pathologic. Patho- Received 14 October 2013 logic rupture has been reported in infectious diseases such as infectious mononucleosis, Accepted 14 January 2014 and hematologic malignancies such as acute and chronic leukemias. Splenomegaly is con- Available online 28 May 2014 sidered the most relevant factor that predisposes to splenic rupture. A 66-year-old man with acute myeloid leukemia evolved from an unclassified myeloproliferative neoplasm, Keywords: complaining of fatigue and mild upper left abdominal pain. He was pale and presented Splenomegaly fever and tachypnea. Laboratory analyses showed hemoglobin 8.3 g/dL, white blood cell 9 9 Leukemia count 278 × 10 /L, platelet count 367 × 10 /L, activated partial thromboplastin time (aPTT) Myeloid ratio 2.10, and international normalized ratio (INR) 1.60. A blood smear showed 62% of Acute myeloblasts. The immunophenotype of the blasts was positive for CD117, HLA-DR, CD13, Leukostasis CD56, CD64, CD11c and CD14. Lactate dehydrogenase was 2384 U/L and creatinine 2.4 mg/dL (normal range: 0.7–1.6 mg/dL). Two sessions of leukapheresis were performed. At the end of the second session, the patient presented hemodynamic instability that culminated in cir- culatory shock and death. -
Atrial Fibrillation and Splenic Infarction Presenting with Unexplained Fever and Persistent Abdominal Pain - a Case Report and Review of the Literature
Case ReportSplenic Infarction Presenting with Unexplained Fever and Persistent Acta Abdominal Cardiol SinPain 2012;28:157-160 Atrial Fibrillation and Splenic Infarction Presenting with Unexplained Fever and Persistent Abdominal Pain - A Case Report and Review of the Literature Cheng-Chun Wei1 and Chiung-Zuan Chiu1,2 Atrial fibrillation is a common clinical problem and may be complicated with events of thromboembolism, especially in patients with valvular heart disease. Splenic infarction is a rare manifestation of the reported cases. The symptoms may vary from asymptomatic to severe peritonitis, though early diagnosis may lessen the probability of severe complications and lead to a good prognosis. We report a 79-year-old man with multiple cardioembolic risk factors who presented with fever and left upper quadrant abdominal pain. To diagnose splenic infarction is challenging for clinicians and requires substantial effort. Early resumption of the anti-coagulation component avoids complications and operation. Key Words: Atrial fibrillation · Splenic infarction · Thromboembolism event · Valvular heart disease INTRODUCTION the patient suffered from severe acute abdominal pain due to splenic infarction. Fortunately, early diagnosis Splenic infarction is a rare cause of an acute abdo- and anticoagulation therapy helped the patient to avoid men. According to a sizeable autopsy series, only 10% emergency surgery and a possible negative outcome. of splenic infarctions had been diagnosed antemortem.1-3 It can occur in a multitude of conditions, with general or local manifestations, and was often a clinical “blind CASE REPORT spot” during the process of diagnosis. However, splenic infarction must be considered in patients with hema- The patient was a 79-year-old man with degenera- tologic diseases or thromboembolic conditions. -
New Jersey Chapter American College of Physicians
NEW JERSEY CHAPTER AMERICAN COLLEGE OF PHYSICIANS ASSOCIATES ABSTRACT COMPETITION 2015 SUBMISSIONS 2015 Resident/Fellow Abstracts 1 1. ID CATEGORY NAME ADDITIONAL PROGRAM ABSTRACT AUTHORS 2. 295 Clinical Abed, Kareem Viren Vankawala MD Atlanticare Intrapulmonary Arteriovenous Malformation causing Recurrent Cerebral Emboli Vignette FACC; Qi Sun MD Regional Medical Ischemic strokes are mainly due to cardioembolic occlusion of small vessels, as well as large vessel thromboemboli. We describe a Center case of intrapulmonary A-V shunt as the etiology of an acute ischemic event. A 63 year old male with a past history of (Dominik supraventricular tachycardia and recurrent deep vein thrombosis; who has been non-compliant on Rivaroxaban, presents with Zampino) pleuritic chest pain and was found to have a right lower lobe pulmonary embolus. The deep vein thrombosis and pulmonary embolus were not significant enough to warrant ultrasound-enhanced thrombolysis by Ekosonic EndoWave Infusion Catheter System, and the patient was subsequently restarted on Rivaroxaban and discharged. The patient presented five days later with left arm tightness and was found to have multiple areas of punctuate infarction of both cerebellar hemispheres, more confluent within the right frontal lobe. Of note he was compliant at this time with Rivaroxaban. The patient was started on unfractionated heparin drip and subsequently admitted. On admission, his vital signs showed a blood pressure of 138/93, heart rate 65 bpm, and respiratory rate 16. Cardiopulmonary examination revealed regular rate and rhythm, without murmurs, rubs or gallops and his lungs were clear to auscultation. Neurologic examination revealed intact cranial nerves, preserved strength in all extremities, mild dysmetria in the left upper extremity and an NIH score of 1. -
Summary Tabulation 10-05-2021
Summary Tabulation 10-05-2021 Active Substance (High Level) COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19) Reaction SOC Reaction PT Serious Non Serious Total Blood and lymphatic system disorders Anaemia 2 1 3 Autoimmune haemolytic anaemia 1 0 1 Coagulopathy 40 21 61 Coombs negative haemolytic anaemia 1 0 1 Disseminated intravascular coagulation 1 0 1 Immune thrombocytopenia 1 0 1 Leukocytosis 1 0 1 Leukopenia 1 0 1 Lymphadenopathy 5 2 7 Lymphopenia 1 0 1 Necrotic lymphadenopathy 0 1 1 Neutropenia 3 1 4 Splenic embolism 1 0 1 Splenic infarction 1 0 1 Thrombocytopenia 19 5 24 Cardiac disorders Acute cardiac event 1 0 1 Angina pectoris 2 0 2 Arrhythmia 4 1 5 Bradycardia 1 1 2 Cardiac arrest 2 0 2 Cardiac failure 2 0 2 Cardiovascular disorder 37 6 43 Myocardial depression 1 0 1 Myocardial infarction 2 0 2 Palpitations 30 3 33 Pericarditis 1 0 1 Sinus tachycardia 1 0 1 Tachycardia 25 3 28 Ear and labyrinth disorders Deafness 1 2 3 Deafness unilateral 4 1 5 Ear congestion 0 2 2 Ear discomfort 3 0 3 Ear pain 9 2 11 Hyperacusis 3 0 3 Sudden hearing loss 0 1 1 Tinnitus 4 1 5 Vertigo 21 3 24 Endocrine disorders Adrenocortical insufficiency acute 1 0 1 Goitre 1 0 1 Eye disorders Amaurosis fugax 1 1 2 Asthenopia 2 0 2 Blindness 3 1 4 Blindness unilateral 4 0 4 Conjunctival haemorrhage 1 1 2 Eye haemorrhage 1 2 3 Eye irritation 1 0 1 Eye pain 3 2 5 Eye swelling 2 0 2 Macular oedema 1 0 1 Miosis 1 0 1 Mydriasis 1 0 1 Ocular discomfort 1 0 1 Papilloedema 1 0 1 Photophobia 5 0 5 Photopsia 1 0 1 Retinal artery thrombosis 2 0 2 Retinal ischaemia 1 0 1 Retinal -
Hyperleukocytosis (Re)Visited- Is It Case Series Always Leukaemia: a Report of Two Pathology Section Cases and Review of Literature Short Communication
Review Article Clinician’s corner Original Article Images in Medicine Experimental Research Miscellaneous Letter to Editor DOI: 10.7860/JCDR/2020/40556.13409 Case Report Postgraduate Education Hyperleukocytosis (Re)Visited- Is it Case Series always Leukaemia: A Report of Two Pathology Section Cases and Review of Literature Short Communication ASHUTOSH RATH1, RICHA GUPTA2 ABSTRACT Hyperleukocytosis is defined as total leukocyte count of more than 100×109/L. Commonly seen in leukaemic conditions, non- leukaemic causes are usually not encountered and thought of. We report two such non-malignant cases of hyperleukocytosis. A six-year old girl presented with fever, cough and respiratory distress with a leukocyte count of 125.97×109/L. Another case is of a two-month old female infant, who presented with fever and respiratory distress and a leukocyte count of 112.27×109/L. The present case thrives to highlight various possible causes of hyperleukocytosis with an emphasis on non-malignant causes. Also, important complications and management of hyperleukocytosis are discussed. Keywords: Benign, Leukocytosis, Leukostasis CASE REPORT 1 for methicillin-resistant Staphylococcus aureus and was started A six-year-old girl was admitted with complaints of fever, non- on intravenous Vancomycin along with supportive care. Serial productive cough for one week and severe respiratory distress for monitoring of TLC revealed a gradual reduction and it returned to the the past one day. There was no other significant history. On physical baseline of 15×109/L after eight days. The patient was discharged examination, the patient had mild pallor. Respiratory examination after 10 days of hospital stay. -
Novel Emergency Medicine Curriculum Utilizing Self- Directed Learning and the Flipped Classroom Method: Hematologic/Oncologic Emergencies Small Group
CURRICULUM Novel Emergency Medicine Curriculum Utilizing Self- Directed Learning and the Flipped Classroom Method: Hematologic/Oncologic Emergencies Small Group Module Michael G Barrie, MD*, Chad L Mayer, MD*, Colin Kaide, MD*, Emily Kauffman, DO*, Jennifer Mitzman, MD*, Matthew Malone, MD*, Daniel Bachmann, MD*, Ashish Panchal, MD*, Howard Werman, MD*, Benjamin Ostro, MD* and Andrew King, MD* *The Ohio State University Wexner Medical Center, Department of Emergency Medicine, Columbus, OH Correspondence should be addressed to Andrew King, MD, FACEP at [email protected], Twitter: @akingermd Submitted: August 6, 2018; Accepted: November 21, 2018; Electronically Published: January 15, 2019; https://doi.org/10.21980/J8VW56 Copyright: © 2019 Barrie, et al. This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) License. See: http://creativecommons.org/licenses/by/4.0/ ABSTRACT: Audience: This curriculum, created and implemented at The Ohio State University Wexner Medical Center, was designed to educate our emergency medicine (EM) residents, intern to senior resident level, as well as medical students and attending physicians. Introduction: Disorders of the hematologic system represent a wide spectrum of disease, including bleeding disorders, coagulopathies, blood cell disorders, and oncology related disorders. Hematologic related problems often complicate other disease processes, including malignancy. The number of patients diagnosed with malignancy is increasing due to many factors, including, but not limited to, an aging population and the increased ability for early detection.1 Patients with oncologic conditions can present in a variety of ways with a variety of complications,2 and understanding the steps in diagnosis and management are important components of any emergency physician’s training. -
Surgical Management of Atraumatic Splenic Rupture
International Surgery Journal Walker AM et al. Int Surg J. 2016 Nov;3(4):2280-2288 http://www.ijsurgery.com pISSN 2349-3305 | eISSN 2349-2902 DOI: http://dx.doi.org/10.18203/2349-2902.isj20163613 Case Report Surgical management of atraumatic splenic rupture Alyssa M. Walker1*, Eugene F. Foley2 1Mountain Area Health Education Center Obstetrics/Gynecology Specialists, 119 Hendersonville Road, Asheville, NC 28803, United States 2University of Wisconsin Hospital and Clinics, 621 Science Dr., Madison, WI 53711, United States Received: 04 September 2016 Accepted: 04 October 2016 *Correspondence: Dr. Alyssa Walker, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Atraumatic splenic rupture (ASR) is a rare, spontaneous, and potentially life-threatening condition that occurs in the absence of trauma; yet the management of ASR has largely defaulted to the treatment algorithm related to blunt splenic trauma. Our aim is to determine if it is appropriate and safe to use the treatment algorithm for blunt splenic trauma in the management of both pathological and non-pathological ASR. We present a case of non-pathological ASR that was successfully managed without splenectomy. A comprehensive literature review on spontaneous ASR was also performed to include publications from January 1975 to February 2015. 914 total cases of ASR were identified: 70 non-pathological and 844 pathological. Overall, 86.5% of these patients received splenectomy based on the presence or absence of traditional signs of clinical instability or deterioration, as utilized in cases of traumatic splenic rupture. -
Sickle-Cell Disorder
SICKLE-CELL DISORDER RMA ID Reference List for RMA161-2 as at June 2017 Number Addae S, Adzaku F, Mohammed S, Annobil S (1990). Sickle cell disease in 46925 permanent residents of mountain and low altitudes in Saudi Arabia. Tropical and Geographical Medicine, Vol 42 pp 342-348. Al Kahtani MA, AlQahtani M, Alshebaily MM, et al (2012). Morbidity and 79578 pregnancy outcomes associated with sickle cell anemia among Saudi women. Int J Gynecol Obstet, 119(3): 224-6. Alayed N, Kezouh A, Oddy L, et al (2014). Sickle cell disease and 79576 pregnancy outcomes: population-based study on 8.8 million births. J Perinat Med, 42(4): 487-92. Al-Salem AH (2013). Massive splenic infarction in children with sickle cell 79587 anemia and the role of splenectomy. Pediatric Surgery International, 29(3): 281-5. Ashley-Koch A, Yang Q, Olney RS (2000). Sickle hemoglobin (Hb S) allele 46299 and sickle cell disease: a HuGE review. Am J Epidemiol, 151(9):839-45. Babosa SM, Farhat SC, Martins LC, et al (2015). Air pollution and children's 79704 health: sickle cell disease. Cadernos de Saude Publica, 31(2): 265-75. Ballas SK (2007). Current issues in sickle cell pain and its management. 46357 Hematology, 2007:97-105. Barbeau P, Woods KF, Ramsey LT, Litaker MS, et al (2001). Exercise in 46995 sickle cell anemia: effect on inflammatory and vasoactive mediators. Endothelium, 8(2):147-55. Basnyat B, Tabin G (2015). Altitude Illness. Harrison's Principles of Internal 80342 Medicine, 19th Edition, 476e. Baum KF, Dunn DT, Maude GH, Serjeant GR (1987). -
An Unusual Etiology of Cytopenia, Diffuse Lymphadenopathy, and Massive Splenomegaly M
Donald and Barbara Zucker School of Medicine Journal Articles Academic Works 2015 "The Great Mimicker": An Unusual Etiology of Cytopenia, Diffuse Lymphadenopathy, and Massive Splenomegaly M. Zaarour Northwell Health C. Weerasinghe Northwell Health E. Moussaly Northwell Health S. Hussein Northwell Health J. P. Atallah Hofstra Northwell School of Medicine Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles Part of the Pathology Commons Recommended Citation Zaarour M, Weerasinghe C, Moussaly E, Hussein S, Atallah J. "The Great Mimicker": An Unusual Etiology of Cytopenia, Diffuse Lymphadenopathy, and Massive Splenomegaly. 2015 Jan 01; 2015():Article 683 [ p.]. Available from: https://academicworks.medicine.hofstra.edu/articles/683. Free full text article. This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more information, please contact [email protected]. Hindawi Publishing Corporation Case Reports in Medicine Volume 2015, Article ID 637965, 6 pages http://dx.doi.org/10.1155/2015/637965 Case Report (The Great Mimicker): An Unusual Etiology of Cytopenia, Diffuse Lymphadenopathy, and Massive Splenomegaly Mazen Zaarour,1 Chanudi Weerasinghe,1 Elias Moussaly,1 Shafinaz Hussein,2 and Jean-Paul Atallah3 1 Department of Medicine, Staten Island University Hospital, North Shore-LIJ Health System, Staten Island, New York, NY 10305, USA 2Department of Pathology, Staten Island University Hospital, North Shore-LIJ Health System, Staten Island, New York, NY 10305, USA 3Division of Hematology and Oncology, Department of Medicine, Staten Island University Hospital, North Shore-LIJ Health System, StatenIsland,NewYork,NY10305,USA Correspondence should be addressed to Mazen Zaarour; [email protected] Received 11 August 2015; Accepted 4 October 2015 Academic Editor: Masahiro Kohzuki Copyright © 2015 Mazen Zaarour et al. -
Hemodialysis Leukopenia. Pulmonary Vascular Leukostasis Resulting from Complement Activation by Dialyzer Cellophane Membranes
Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. P R Craddock, … , K L Brighan, H S Jacob J Clin Invest. 1977;59(5):879-888. https://doi.org/10.1172/JCI108710. Research Article Acute leukopenia occurs in all patients during the first hour of hemodialysis with cellophanemembrane equipment. This transient cytopenia specifically involves granulocytes and monocytes, cells which share plasma membrane reactivity towards activated complement components. The present studies document that complement is activated during exposure of plasma to dialyzer cellophane, and that upon reinfusion of this plasma into the venous circulation, granulocyte and monocyte entrapment in the pulmonary vasculature is induced. During early dialysis, conversion of both C3 and factor B can be demonstrated in plasma as it leaves the dialyzer. Moreover, simple incubation of human plasma with dialyzer cellophane causes conversion of C3 and factor B, accompanied by depletion of total hemolytic complement and C3 but sparing of hemolytic C1. Reinfusion of autologous, cellophane-incubated plasma into rabbits produces selective granulocytopenia and monocytopenia identical to that seen in dialyzed patients. Lungs from such animals reveal striking pulmonary vessel engorgement with granulocytes. The activated complement component(s) responsible for leukostasis has an approximate molecular weight of 7,000-20,000 daltons. Since it is generated in C2-deficient plasma and is associated with factor B conversion, it is suggested that activation of complement by dialysis is predominantly through the altermative pathway. Find the latest version: https://jci.me/108710/pdf Hemodialysis Leukopenia PULMONARY VASCULAR LEUKOSTASIS RESULTING FROM COMPLEMENT ACTIVATION BY DIALYZER CELLOPHANE MEMBRANES PHILIP R. -
Statistical Analysis Plan
Cover Page for Statistical Analysis Plan Sponsor name: Novo Nordisk A/S NCT number NCT03061214 Sponsor trial ID: NN9535-4114 Official title of study: SUSTAINTM CHINA - Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Document date: 22 August 2019 Semaglutide s.c (Ozempic®) Date: 22 August 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL Clinical Trial Report Status: Final Appendix 16.1.9 16.1.9 Documentation of statistical methods List of contents Statistical analysis plan...................................................................................................................... /LQN Statistical documentation................................................................................................................... /LQN Redacted VWDWLVWLFDODQDO\VLVSODQ Includes redaction of personal identifiable information only. Statistical Analysis Plan Date: 28 May 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL UTN:U1111-1149-0432 Status: Final EudraCT No.:NA Page: 1 of 30 Statistical Analysis Plan Trial ID: NN9535-4114 Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Author Biostatistics Semaglutide s.c. This confidential document is the property of Novo Nordisk. No unpublished information contained herein may be disclosed without prior written approval from Novo Nordisk. Access to this document must be restricted to relevant parties.This -
Splenic Tuberculosis – a Rare Presentation Kafil Akhtar1, Sadaf Haiyat1, Saquib Alam1, Atia Zakaur Rab2
CASE REPORT Splenic Tuberculosis – A Rare Presentation Kafil Akhtar1, Sadaf Haiyat1, Saquib Alam1, Atia Zakaur Rab2 1Department of Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India, 2Department of General Surgery, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India ABSTRACT Tuberculosis (TB) is an important health problem in developing countries, mostly seen in immunocompromised patients. Splenic TB is rare and develops as the result of either dissemination of pulmonary or biliary TB, following either ingestion of contaminated food or infected sputum. In developed countries, it is seen in patients with human immunodeficiency virus, but it is associated with significant mortality and morbidity in developing countries. We report a case of splenic TB in a 23-year-old male who presented with fever and left hypochondriac mass. A computerized tomography scan of the abdomen showed splenic enlargement with many hypodense solid to cystic lesions with ill-defined boundary. Exploratory splenectomy was performed and histological examination revealed chronic granulomatous inflammation with numerous epithelioid cells, Langhans giant cells with foci of caseous necrosis consistent with TB. He responded well with four-drug antitubercular treatment. Key words: Histopathology, spleen, tuberculosis INTRODUCTION CASE REPORT plenic tuberculosis (TB) is an extremely rare form A 23-year-old man presented to the medicine clinics with of extrapulmonary TB.[1] Non-specific clinical a history of frequent fevers for the past 2 months and Spresentation, difficulties in confirming the diagnosis, left hypochondriac fullness and discomfort for 15 days. and its subsequent treatment may lead to undue delay in the There was no history of throat pain, chest pain, cough with management of the patient.